← Evidence map

ArticleScience advances2021

A nonviral, nonintegrating DNA nanovector platform for the safe, rapid, and persistent manufacture of recombinant T cells.

Matthias Bozza et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

52 papers cite it

2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 33853779